@article{fa91b3f0d13a45ccac0d16e4d18006bb,
title = "Perivascular Stromal Cells Instruct Glioblastoma Invasion, Proliferation, and Therapeutic Response within an Engineered Brain Perivascular Niche Model",
abstract = "Glioblastoma (GBM) tumor cells are found in the perivascular niche microenvironment and are believed to associate closely with the brain microvasculature. However, it is largely unknown how the resident cells of the perivascular niche, such as endothelial cells, pericytes, and astrocytes, influence GBM tumor cell behavior and disease progression. A 3D in vitro model of the brain perivascular niche developed by encapsulating brain-derived endothelial cells, pericytes, and astrocytes in a gelatin hydrogel is described. It is shown that brain perivascular stromal cells, namely pericytes and astrocytes, contribute to vascular architecture and maturation. Cocultures of patient-derived GBM tumor cells with brain microvascular cells are used to identify a role for pericytes and astrocytes in establishing a perivascular niche environment that modulates GBM cell invasion, proliferation, and therapeutic response. Engineered models provide unique insight regarding the spatial patterning of GBM cell phenotypes in response to a multicellular model of the perivascular niche. Critically, it is shown that engineered perivascular models provide an important resource to evaluate mechanisms by which intercellular interactions modulate GBM tumor cell behavior, drug response, and provide a framework to consider patient-specific disease phenotypes.",
keywords = "angiocrine, glioblastoma, hydrogel, invasion, tumor, vascular",
author = "Ngo, {Mai T.} and Sarkaria, {Jann N.} and Harley, {Brendan A.C.}",
note = "Funding Information: The authors thank Samantha Zambuto (UIUC), Alireza Sohrabi (UT‐Austin), and Mark Schroeder (Mayo Clinic) for technical guidance that aided in experimental design and execution. The authors thank Zeng Hu (Mayo Clinic) for preparing and shipping primary tumor cells from patient‐derived xenograft colonies. This work was supported by the National Cancer Institute of the National Institutes of Health (R01 CA256481, R01 CA197488) and the National Science Foundation Graduate Research Fellowship (DGE 1144245 to M.T.N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors also acknowledge additional funding provided by the Department of Chemical and Biomolecular Engineering and the Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana‐Champaign. Funding Information: The authors thank Samantha Zambuto (UIUC), Alireza Sohrabi (UT-Austin), and Mark Schroeder (Mayo Clinic) for technical guidance that aided in experimental design and execution. The authors thank Zeng Hu (Mayo Clinic) for preparing and shipping primary tumor cells from patient-derived xenograft colonies. This work was supported by the National Cancer Institute of the National Institutes of Health (R01 CA256481, R01 CA197488) and the National Science Foundation Graduate Research Fellowship (DGE 1144245 to M.T.N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors also acknowledge additional funding provided by the Department of Chemical and Biomolecular Engineering and the Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana-Champaign. Publisher Copyright: {\textcopyright} 2022 The Authors. Advanced Science published by Wiley-VCH GmbH.",
year = "2022",
month = nov,
day = "3",
doi = "10.1002/advs.202201888",
language = "English (US)",
volume = "9",
journal = "Advanced Science",
issn = "2198-3844",
publisher = "Wiley-VCH Verlag",
number = "31",
}